Alexza Pharmaceuticals Inc (ALXA)

NASDAQ
0.9200
0.0000(0.00%)
  • Volume:
    0
  • Day's Range:
    0.9200 - 0.9560
  • 52 wk Range:
    0.0000 - 0.0000

ALXA Overview

Prev. Close
0.92
Day's Range
0.92-0.956
Revenue
5.04M
Open
0.93
52 wk Range
0-0
EPS
-1.22
Volume
0
Market Cap
20.45M
Dividend (Yield)
0.00
(N/A)
Average Vol. (3m)
454,831
P/E Ratio
-
Beta
0.8
1-Year Change
0%
Shares Outstanding
21,750,615
Next Earnings Date
-
What is your sentiment on Alexza?
or
Vote to see community's results!

Alexza Pharmaceuticals Inc News

Alexza Pharmaceuticals Inc Analysis

Alexza Pharmaceuticals Inc Company Profile

Alexza Pharmaceuticals Inc Company Profile

Employees
27

Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Its product also includes ADASUVE, which contains loxapine as API is developed for the treatment of agitation associated with schizophrenia or bipolar disorder. It has initiated a Phase IIa proof-of-concept study for AZ-002 in patients with epilepsy and has completed Phase I testing for AZ-007.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • Ghost town
    0